Highlights From CROI

Share

Program Content

Activities

  • CROI Hot Topics
    Preview of Hot Topics at CROI 2019: My Picks
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 01, 2019

    Expires: February 28, 2020

  • Long-Acting Injectable ART
    A New Chapter in ART? Implications of ATLAS and FLAIR Results From CROI 2019
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 10, 2019

    Expires: May 08, 2020

  • New Data From CROI 2019
    Clinical Impact of New HIV Data From CROI 2019
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 22, 2019

    Expires: March 20, 2020

Activities

DISCOVER
DISCOVER: Phase III Study of Emtricitabine/Tenofovir Alafenamide vs Emtricitabine/Tenofovir Disoproxil Fumarate for HIV PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

PrEP and Drug Resistance
Effects of PrEP on Drug Resistance and Acute HIV Infection in New York City Surveillance Population
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

ATLAS
ATLAS: Week 48 Results From Phase III Study of Switching to Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Patients With No Prior Virologic Failure
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 09, 2019

Expires: March 07, 2020

FLAIR
FLAIR: Switch to Long-Acting CAB + RPV Following Oral Induction in ART-Naive Patients Noninferior to Continued DTG/ABC/3TC at Week 48
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

DAWNING
DAWNING: High Virologic Response Rates at Week 48 With DTG-Based ART Regardless of Baseline NRTI RAMs and Second-Line NRTI Use
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2019

Expires: March 11, 2020

Opioid Overdose Deaths in HIV
Increased Deaths From Opioid Overdose Among Persons With HIV Infection, 2011-2015
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

HPTN 077
HPTN 077: No Significant Weight Gain at Week 41 With Long-Acting CAB vs PBO in HIV-Uninfected Persons at Low Risk for Infection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

NICHD P1081
NICHD P1081: Improved Virologic Suppression at Delivery With RAL- vs EFV-Based ART in Pregnant Women With HIV Infection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 07, 2019

Expires: March 05, 2020

DolPHIN-2
DolPHIN-2: More Rapid Virologic Suppression With DTG- vs EFV-Based ART Initiated in Late Pregnancy
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2019

Expires: March 06, 2020

Study 380-1474
GS-US-380-1474: Switch to BIC/FTC/TAF Safely Maintains Virologic Suppression at Week 48 in Children and Adolescents With HIV Infection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2019

Expires: March 09, 2020

Supporters

Supported by educational grants from

Gilead Text

Janssen

Merck Human Health HIV

ViiV Healthcare